Skip to content

Clinical trials

Completed Hematologic Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Status: Completed Country / region: Germany Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20041
20061
20071
20091
20101
20114
20121
20132
20141
20151
20162
20201
20213
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kiadis Pharma3
Novartis Pharmaceuticals3
AstraZeneca2
Fred Hutchinson Cancer Center2
4SC AG1
AGC Biologics S.p.A.1
Amgen1
Bayer1
Beckman Coulter, Inc.1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms26
Leukemia, Myeloid, Acute7
Multiple Myeloma6
Myelodysplastic Syndromes6
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, Large B-Cell, Diffuse4
Graft vs Host Disease3
Hodgkin Disease3
Lymphoma, Mantle-Cell3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.